Coleman Research Group’s Technology, Media & Telecom Group facilitates consultations between our clients (institutional investors) and leading healthcare professionals on a wide variety of topics including pharmaceuticals, biotechnology, clinical research, medical devices, healthcare providers, insurance, and regulatory issues.
Our TMT network spans technology industries across the globe and includes doctors, researchers, scientists, healthcare executives, consultants, and former regulatory officials.
********************************
Pump Away Shingles Pain?
May 7, 2009
A surgically implanted pump that delivers medication to the spinal fluid helps reduce the persistent pain that can linger in some patients after they recover from shingles, according to a new study.
"All patients showed a greater than 50% improvement in pain control," says Andrew J. Fabiano, MD, a senior resident at the University of Buffalo who was scheduled to present the findings yesterday at the American Association of Neurological Surgeons meeting in San Diego. "The patients describe a dramatic improvement in pain,'' he says. The study follow-up averaged nearly six years.
Shingles affects about a million people a year in the U.S., according to the Association for Healthcare Research and Quality, with risk being much higher for people 65 and older.
********************************
Blood Pressure Pill Exforge HCT Approved
May 7, 2009
The FDA has approved Exforge HCT, which combines three blood pressure drugs -- amlodipine, valsartan, and hydrochlorothiazide -- into one pill.
Amlodipine is a calcium-channel blocker. Valsartan is an angiotensin-receptor blocker (ARB). Hydrochlorothiazide is a diuretic.
In June 2007, the FDA approved Exforge, which contains amlodipine and valsartan. The newly approved Exforge HCT adds hydrochlorothiazide.
The FDA approved Exforge HCT based on a clinical trial that included more than 2,000 patients, according to a news release from Novartis, the drug company that makes Exforge and Exforge HCT.
********************************
To learn more about Coleman Research Group please visit the Coleman Research Group website or at any of the links below:
About Coleman Research Group
Coleman Research Group Testimonials
Coleman Research Group on LinkedIn
Coleman Research Group on Facebook
Coleman Research Group on Flickr
Coleman Research Group on Squidoo
Coleman Research Group on Namyz
Coleman Research Group on Twitter
Coleman Research Group on Review-Inc
Coleman Research Group Contact Us
Coleman Research Group on 800 Review
Coleman Research Group on Blogspot
Coleman Research Group on Jobster
Coleman Research Group's Knowledge Broker
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment